shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name,Batch ID,"Amount, mg (left)"
EDJ-MED-b774e9fe-1,Z5261485095,C21H18ClN3O2,Racemic or presumed racemic or meso,379.839,97.68,COVID-19,,,0,40,20,1326826-Y40-33,03_A,CC(=O)N1CCC=2C=CC(Cl)=CC2C1C(=O)NC=3C=NC=C4C=CC=CC34,"2-acetyl-7-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide",H3513481,59.3
MAT-POS-90fd5f68-10,Z5261485113,C19H18ClN3O3S,Achiral,403.882,100,COVID-19,,,0,40,20,1326826-Y40-33,03_B,CN(C=1C=CC=2C(NC(=O)CC=3C=CC=C(Cl)C3)=CN=CC2C1)S(=O)(=O)C,2-(3-chlorophenyl)-N-[7-(N-methylmethanesulfonamido)isoquinolin-4-yl]acetamide,H3553897,20.7
ALP-POS-4483ae88-4,Z5395340386,C18H18ClN3O3S,Racemic or presumed racemic or meso,391.871,100,COVID-19,,,0,40,20,1326826-Y40-33,03_C,ClC=1C=CC2=C(C1)C(CNS2(=O)=O)C(=O)NC=3C=NC=C4CCCCC34,"6-chloro-1,1-dioxo-N-(5,6,7,8-tetrahydroisoquinolin-4-yl)-3,4-dihydro-2H-1??,2-benzothiazine-4-carboxamide",H3549991,28.8
MAT-POS-22373164-1,Z5372150753,C26H26ClN5O5S2,Racemic or presumed racemic or meso,588.098,100,COVID-19,,,0,40,20,1326826-Y40-33,03_D,CN(C=1C=CC=2C(NC(=O)C3CN(CC=4C=CC(Cl)=CC34)S(=O)(=O)CC5(CC5)C#N)=CN=CC2C1)S(=O)(=O)C,"6-chloro-2-[(1-cyanocyclopropyl)methanesulfonyl]-N-[7-(N-methylmethanesulfonamido)isoquinolin-4-yl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3553896,38.8
EDJ-MED-ede277f6-12,Z5367986372,C25H26ClN3O7S3,Racemic or presumed racemic or meso,612.137,98.73,COVID-19,,,0,40,20,1326826-Y40-33,03_E,CC1(CS(=O)(=O)N2CC(C(=O)NC=3C=NC=C4C=C(C=CC34)S(=O)(=O)C)C=5C=C(Cl)C=CC5C2)CS(=O)(=O)C1,"6-chloro-N-(7-methanesulfonylisoquinolin-4-yl)-2-[(3-methyl-1,1-dioxo-1??-thietan-3-yl)methanesulfonyl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3545011,18.8
EDJ-MED-968bafd9-2,Z5335933762,C25H24ClN3O7S2,Racemic or presumed racemic or meso,578.056,96.95,COVID-19,,,0,40,20,1326826-Y40-33,03_F,COC1(CS(=O)(=O)N2CC(C(=O)NC=3C=NC=C4C=C(C=CC34)S(=O)(=O)C)C=5C=C(Cl)C=CC5C2=O)CC1,"6-chloro-N-(7-methanesulfonylisoquinolin-4-yl)-2-[(1-methoxycyclopropyl)methanesulfonyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3550035,3.4
ALP-POS-4483ae88-4a,Z5401334701,C19H20ClN3O3S,Racemic or presumed racemic or meso,405.898,91,COVID-19,,,0,40,20,1326826-Y40-33,03_G,CC1(CNS(=O)(=O)C=2C=CC(Cl)=CC21)C(=O)NC=3C=NC=C4CCCCC34,"6-chloro-4-methyl-1,1-dioxo-N-(5,6,7,8-tetrahydroisoquinolin-4-yl)-3,4-dihydro-2H-1??,2-benzothiazine-4-carboxamide",H3566325,10.3
MAT-POS-97ec4bd1-2,Z5367986359,C27H27ClN4O4S,Racemic or presumed racemic or meso,539.045,95.25,COVID-19,,,0,40,20,1326826-Y40-33,03_H,CC(C)(O)C=1C=CC=2C=NC=C(NC(=O)C3CN(CC=4C=CC(Cl)=CC34)S(=O)(=O)CC5(CC5)C#N)C2C1,"6-chloro-2-[(1-cyanocyclopropyl)methanesulfonyl]-N-[6-(2-hydroxypropan-2-yl)isoquinolin-4-yl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3561623,14.6
MAT-POS-b4d6b7fc-2,Z5372150758,C23H22ClN5O5S,Racemic or presumed racemic or meso,515.969,100,COVID-19,,,0,40,20,1326826-Y40-33,03_I,CNC(=O)CN1CC(C(=O)NC=2C=NC=C3C=C(NS(=O)(=O)C)C=CC23)C=4C=C(Cl)C=CC4C1=O,"6-chloro-N-(7-methanesulfonamidoisoquinolin-4-yl)-2-[(methylcarbamoyl)methyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3567511,23.2